Tele: 561.316.3330
Breaking Medical Device News

Monday, October 18, 2021
HomeHEALTHSputnik V Vaccine Is Delivered to Argentina

Sputnik V Vaccine Is Delivered to Argentina

December 28, 2020

Sputnik V Vaccine developed by Russian scientists from the Gamaleya National Center of Epidemiology and Microbiology with the support of the Russian Direct Investment Fund (RDIF) has been delivered to Argentina.

The issues related to the transfer of technology for the production of the Sputnik V vaccine abroad and its supply to Argentina have been addressed with the active assistance from the Russian Direct Investment Fund, headed by Kirill Dmitriev, and the Russia-Argentina Business Council, headed by Andrey Guryev.

On the initiative of the RDIF and the Business Council, numerous high-level meetings of representatives of Argentinian and Russian public and private organizations to discuss best practices to counter the spread of coronavirus took place throughout the year.

The possibility of producing the Sputnik V vaccine in Argentina was first discussed during a September meeting of the co-chairs of the Intergovernmental Russian-Argentine Commission of Trade-Economic and Scientific-Technical Cooperation.

“We are grateful to RDIF, Russian members of the Russia-Argentina Business Council, and particularly its Chairman Andrey Guryev for their efforts that have enabled the start of the largest mass vaccination campaign in Argentina’s history.” T

Guryev adds, “This is a great and friendly step that confirms a true strategic partnership between our two countries and strengthens trust and cooperation among Argentinian and Russian business circles. This Christmas Eve, brought us hope in such a difficult context,” said Amalia Sáenz, Chair of the Argentine-Russian Business Council.

“The vaccines against COVID-19 developed in Russia are clearly of great interest internationally. Latin American countries are among those most affected by the pandemic. In this difficult environment, supplying a batch of Sputnik V vaccines to our strategic partner has allowed Argentina to follow Russia, which has already begun a large-scale vaccination program against COVID-19,” Andrey Guryev, Сhair of the Russia-Argentina Business Council, concluded.

“The delivery of the Sputnik V vaccine to Argentina is a truly historic moment and an excellent example of cooperation between our countries. The entire nation watched as the plane carrying the first batch of Sputnik V vaccines landed at Ezeiza Airport on Christmas, giving great hope that this is the beginning of a new era without COVID. The “V” in the name of our vaccine stands for “Victory,” and we wish the people of Argentina a decisive victory over this disease. We support the decision of the Argentine government to include our vaccine in its national portfolio,” commented Kirill Dmitriev, CEO of the Russian Direct Investment Fund.

Medical Device News Magazine
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected


Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy